Elliott Jonathan E, Duke Joseph W, Hawn Jerold A, Halliwill John R, Lovering Andrew T
University of Oregon, Department of Human Physiology, Eugene, OR, USA.
Oregon Heart and Vascular Institute, Cardiology, Springfield, OR, USA.
J Physiol. 2014 Oct 15;592(20):4537-53. doi: 10.1113/jphysiol.2014.274829. Epub 2014 Aug 1.
Blood flow through intrapulmonary arteriovenous anastomoses (IPAVAs) has been demonstrated to increase in healthy humans during a variety of conditions; however, whether or not this blood flow represents a source of venous admixture (Q̇ VA /Q̇T) that impairs pulmonary gas exchange efficiency (i.e. increases the alveolar-to-arterial PO2 difference (A-aDO2)) remains controversial and unknown. We hypothesized that blood flow through IPAVAs does provide a source of Q̇ VA /Q̇T. To test this, blood flow through IPAVAs was increased in healthy humans at rest breathing room air and 40% O2: (1) during intravenous adrenaline (epinephrine) infusion at 320 ng kg(-1) min(-1) (320 ADR), and (2) with vagal blockade (2 mg atropine), before and during intravenous adrenaline infusion at 80 ng kg(-1) min(-1) (ATR + 80 ADR). When breathing room air the A-aDO2 increased by 6 ± 2 mmHg during 320 ADR and by 5 ± 2 mmHg during ATR + 80 ADR, and the change in calculated Q̇ VA /Q̇T was +2% in both conditions. When breathing 40% O2, which minimizes contributions from diffusion limitation and alveolar ventilation-to-perfusion inequality, the A-aDO2 increased by 12 ± 7 mmHg during 320 ADR, and by 9 ± 6 mmHg during ATR + 80 ADR, and the change in calculated Q̇ VA /Q̇T was +2% in both conditions. During 320 ADR cardiac output (Q̇T) and pulmonary artery systolic pressure (PASP) were significantly increased; however, during ATR + 80 ADR only Q̇T was significantly increased, yet blood flow through IPAVAs as detected with saline contrast echocardiography was not different between conditions. Accordingly, we suggest that blood flow through IPAVAs provides a source of intrapulmonary shunt, and is mediated primarily by increases in Q̇T rather than PASP.
在多种情况下,健康人体内经肺内动静脉吻合支(IPAVA)的血流量已被证实会增加;然而,这种血流量是否代表静脉血掺杂(Q̇VA/Q̇T)的一个来源,进而损害肺气体交换效率(即增加肺泡-动脉氧分压差(A-aDO2)),仍存在争议且尚不明确。我们假设经IPAVA的血流量确实提供了Q̇VA/Q̇T的一个来源。为了验证这一点,在静息状态下呼吸室内空气和40%氧气时,增加健康人体内经IPAVA的血流量:(1)在以320 ng kg⁻¹ min⁻¹(320 ADR)静脉输注肾上腺素期间,以及(2)在迷走神经阻滞(2 mg阿托品)时,以及在以80 ng kg⁻¹ min⁻¹(ATR + 80 ADR)静脉输注肾上腺素之前和期间。当呼吸室内空气时,在320 ADR期间A-aDO2增加6±2 mmHg,在ATR + 80 ADR期间增加5±2 mmHg,两种情况下计算得出的Q̇VA/Q̇T变化均为+2%。当呼吸40%氧气时,这可将扩散限制和肺泡通气-灌注不均一性的影响降至最低,在320 ADR期间A-aDO2增加12±7 mmHg,在ATR + 80 ADR期间增加9±6 mmHg,两种情况下计算得出的Q̇VA/Q̇T变化均为+2%。在输注320 ADR期间心输出量(Q̇T)和肺动脉收缩压(PASP)显著增加;然而,在ATR + 80 ADR期间只有Q̇T显著增加,但经盐水对比超声心动图检测,两种情况下经IPAVA的血流量并无差异。因此,我们认为经IPAVA的血流量提供了肺内分流的一个来源,并且主要由Q̇T增加介导,而非PASP增加。